Kliacef (Cefaclor)

Cefaclor works by binding to penicillin‑binding proteins on the bacterial cell wall, blocking the final step of peptidoglycan cross‑linking. This inhibition weakens the wall, causing osmotic lysis and death of susceptible Gram‑positive and some Gram‑negative bacteria, thereby clearing the infection.

The dosage of Kliacef is individualized by the prescribing healthcare professional. The prescriber selects the amount, frequency and duration based on the type and severity of infection, patient age, weight and renal function, following local clinical guidelines.

Safety data for cefaclor in pregnancy and lactation are limited. It should be used only when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss risks with their healthcare provider.

To order Kliacef, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details and any necessary import documentation.

Both Kliacef (cefaclor) and amoxicillin belong to the beta‑lactam class, but cefaclor is a second‑generation cephalosporin offering broader activity against certain Gram‑negative organisms and better stability against some beta‑lactamases. Amoxicillin may be preferred for infections where narrow‑spectrum coverage is sufficient, while cefaclor is chosen when a broader spectrum is needed or when a patient has a mild penicillin allergy.

Kliacef tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture and direct light, and ensure the packaging remains tightly closed until use.

Kliacef is taken orally as a tablet. The tablet should be swallowed whole with a glass of water. It can be taken with or without food, but consistent timing with meals may help reduce gastrointestinal upset. Follow the prescriber’s instructions regarding dosing intervals.

The most serious risks include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, and rare skin disorders like Stevens‑Johnson syndrome or toxic epidermal necrolysis. Patients should seek immediate medical attention if they develop difficulty breathing, widespread rash, persistent diarrhea or signs of severe infection.

Kliacef should not be used by individuals with a known hypersensitivity to cefaclor, other cephalosporins or penicillins. It is also contraindicated in patients with severe renal impairment unless the dose is appropriately adjusted, and it should be avoided in those who have experienced severe cutaneous adverse reactions to beta‑lactam antibiotics.